Company Showcase Oncology

Aptorum

Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group’s current drug pipeline include indications in orphan diseases, infectious diseases and metabolic diseases and a number of which are targeted to enter clinical trial phases in 2020. Aptorum Group also operates a woman’s health supplement business whose Dioscorea Opposita Bioactive Nutraceutical Tablets are currently being commercialized.

Aptorum Group Limited(纳斯达克股票代码:APM)是一家制药公司,致力于开发和商业化新型疗法以解决未满足的医疗需求。 Aptorum Group当前的药品开发渠道包括孤儿疾病,传染病和代谢性疾病的适应症,其中一些目标将于2020年进入临床试验阶段。AptorumGroup还经营着一家女性保健品业务,其Dioscorea Opposita生物活性营养片剂目前正在商业化。

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s